Prediabetic patients Coenzyme Q10 CoQ10 Ubiquinone Diabetes
Conditions
Interventions
Daily ubiquinol with the dosage of 100 mg for 12 weeks
A 500-mg soft gelatin capsule containing 100 mg of ubiquinol (Kaneka ubiquinolTM) emulsified with 400 mg of Medium Chain Triglycerides (MCT) oil
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Sponsors
Anti-aging and Regenerative Medicine, College of Integrative Medicine, Dhurakij Pundit University, Bangkok, Thailand
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Participants aged 18-60 years with prediabetes defined as having fasting plasma glucose between 100 and 125 mg/dl
Exclusion criteria
Exclusion criteria: Diagnosed of diabetes or use of oral hypoglycemic agents, use of vitamins or other antioxidant supplements within the past 6 months, uncontrolled hypertension, diagnosed or previous history of cardiovascular disease, renal insufficiency, and pregnancy or breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metabolic profile 12 weeks FPG, HbA1C, fasting insulin, HOMA-IR, total cholesterol, LDL, HDL, and TG | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety 12 weeks Hb, Hct, WBC, platelet, Cr, AST, and ALT | — |
Countries
Thailand
Contacts
Public ContactPasita Palakornkitti
Anti-aging and Regenerative Medicine, College of Integrative Medicine, Dhurakij Pundit University
Outcome results
None listed